Further bioinformatics analysis using TIMER revealed that HOXD1 positively correlated with immune infiltration, thus indicating that HOXD1 could be an indicator for the use of immunotherapeutic agents in patients with RCC. Here, HOXD1 is linked to renal cell carcinoma.